Literature DB >> 3922535

Bronchial hyperreactivity to leucotriene D4 and histamine in exogenous asthma.

H Bisgaard, S Groth, F Madsen.   

Abstract

Reactivity of the small and large airways to inhaled leucotriene D4, one of the leucotrienes that constitute slow reacting substance of anaphylaxis, was studied in eight patients with exogenous asthma and nine healthy subjects with no history of atopy. Non-cumulative dose response relations were constructed for leucotriene D4 in a randomised, double blind set up. Reactivity to the leucotriene was compared with reactivity to histamine in the two groups. Both groups reacted to leucotriene D4 with significant airway obstruction evident in forced expiratory volume in one second (FEV1), peak expiratory flow rate, maximal expiratory flow rate at 30% of forced vital capacity estimated from a partial flow volume curve initiated at 50% of vital capacity (V30), and an increase in volume of trapped gas. The airways of the patients were significantly (p less than 0.01) more reactive to leucotriene D4 than those of the controls. The differences were in order of magnitude, 10(2)-10(3) for FEV1 but only about 15 for V30 (p less than 0.05). The hyperreactivity of the airways of the asthmatic subjects to leucotriene D4 was comparable to that to histamine. Inhalation of leucotriene D4 caused pronounced dyspnoea only among the patients. The findings suggest a role for leucotriene D4 in human bronchial asthma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3922535      PMCID: PMC1415696          DOI: 10.1136/bmj.290.6480.1468

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  13 in total

Review 1.  Standardization of allergen extracts with appropriate methods. The combined use of skin prick testing and radio-allergosorbent tests.

Authors:  K Aas; A Backman; L Belin; B Weeke
Journal:  Allergy       Date:  1978-06       Impact factor: 13.146

2.  Leukotrienes: a new class of mediators of immediate hypersensitivity reactions and inflammation.

Authors:  B Samuelsson
Journal:  Adv Prostaglandin Thromboxane Leukot Res       Date:  1983

3.  Effects of leukotriene D on the airways in asthma.

Authors:  M Griffin; J W Weiss; A G Leitch; E R McFadden; E J Corey; K F Austen; J M Drazen
Journal:  N Engl J Med       Date:  1983-02-24       Impact factor: 91.245

Review 4.  Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance.

Authors:  F E Hargreave; G Ryan; N C Thomson; P M O'Byrne; K Latimer; E F Juniper; J Dolovich
Journal:  J Allergy Clin Immunol       Date:  1981-11       Impact factor: 10.793

5.  Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects.

Authors:  N C Barnes; P J Piper; J F Costello
Journal:  Thorax       Date:  1984-07       Impact factor: 9.139

6.  Slow-reacting substances (leukotrienes) contract human airway and pulmonary vascular smooth muscle in vitro.

Authors:  C J Hanna; M K Bach; P D Pare; R R Schellenberg
Journal:  Nature       Date:  1981-03-26       Impact factor: 49.962

7.  Leukotriene D4 induces bronchoconstriction in man.

Authors:  H Bisgaard; S Groth; H Dirksen
Journal:  Allergy       Date:  1983-08       Impact factor: 13.146

8.  Changes in volume of trapped gas in the lungs during provoked asthma followed by beta-2 receptor stimulation.

Authors:  K Bülow; M Arborelius; P Christensson; B Lilja
Journal:  Respiration       Date:  1978       Impact factor: 3.580

9.  Leukotrienes are potent constrictors of human bronchi.

Authors:  S E Dahlén; P Hedqvist; S Hammarström; B Samuelsson
Journal:  Nature       Date:  1980-12-04       Impact factor: 49.962

10.  Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4, and E4.

Authors:  S E Dahlén; G Hansson; P Hedqvist; T Björck; E Granström; B Dahlén
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

View more
  11 in total

Review 1.  Biochemistry and physiology of the leukotrienes.

Authors:  N C Barnes; L J Smith
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

Review 2.  Leukotriene activity modulation in asthma.

Authors:  S L Spector
Journal:  Drugs       Date:  1997-09       Impact factor: 9.546

3.  Effect of RG 12525, an oral leukotriene D4 antagonist, on the airway response to inhaled leukotriene D4 in subjects with mild asthma.

Authors:  I Wahedna; A S Wisniewski; A E Tattersfield
Journal:  Br J Clin Pharmacol       Date:  1991-10       Impact factor: 4.335

4.  Effect of inhaled piriprost (U-60, 257) a novel leukotriene inhibitor, on allergen and exercise induced bronchoconstriction in asthma.

Authors:  J S Mann; C Robinson; A Q Sheridan; P Clement; M K Bach; S T Holgate
Journal:  Thorax       Date:  1986-10       Impact factor: 9.139

5.  Serum from NSAID-treated patients attenuates the capacity of rat leukocytes to synthesize leukotriene B4.

Authors:  H Gutheil; O H Nielsen; T M Hansen; B S Thomsen; I Ahnfelt-Rønne
Journal:  Inflamm Res       Date:  1996-01       Impact factor: 4.575

6.  Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness.

Authors:  T B Casale; D Wood; H B Richerson; S Trapp; W J Metzger; D Zavala; G W Hunninghake
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

7.  L-648,051, a novel cysteinyl-leukotriene antagonist is active by the inhaled route in man.

Authors:  J M Evans; N C Barnes; J T Zakrzewski; D G Sciberras; E G Stahl; P J Piper; J F Costello
Journal:  Br J Clin Pharmacol       Date:  1989-08       Impact factor: 4.335

8.  The contribution of histamine release to bronchoconstriction provoked by inhaled benzalkonium chloride in asthma.

Authors:  K A Miszkiel; R Beasley; P Rafferty; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

Review 9.  Leukotrienes as a target in asthma therapy.

Authors:  N Chanarin; S L Johnston
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

10.  The influence of ipratropium bromide and sodium cromoglycate on benzalkonium chloride-induced bronchoconstriction in asthma.

Authors:  K A Miszkiel; R Beasley; S T Holgate
Journal:  Br J Clin Pharmacol       Date:  1988-09       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.